ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,654Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 15

$2.34M Total Retail Price of All Prescriptions

Rank: 1 out of 15

608 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 608 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 608 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 23,722 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
EXELON 784 764 1 41
POTASSIUM CHLORIDE 728 599 2 10
FUROSEMIDE 702 526 3 2
HYDROCODONE-ACETAMINOPHEN 672 403 S3 4 5
WARFARIN SODIUM 666 502 5 13
OMEPRAZOLE 631 491 6 8
LEVOTHYROXINE SODIUM 617 465 7 1
NAMENDA 609 577 8 12
ESCITALOPRAM OXALATE 600 465 9 16
METOPROLOL TARTRATE 590 465 10 9
QUETIAPINE FUMARATE 521 399 11 20
LISINOPRIL 488 317 12 4
MEGESTROL ACETATE 462 403 R 10 13 77
GABAPENTIN 458 293 14 21
PRAVASTATIN SODIUM 425 309 15 15
POLYETHYLENE GLYCOL 3350 422 331 16 17
METFORMIN HCL 420 292 17 7
OLANZAPINE 417 308 18 47
METHYLPHENIDATE HCL 414 349 10 19 78
NOVOLOG 381 282 20 59
TRIAMTERENE-HCTZ 373 272 21 68
NEXIUM 372 279 22 24
RISPERIDONE 371 259 23 28
LEVETIRACETAM 342 208 24 39
SIMVASTATIN 327 205 25 6
RANITIDINE HCL 318 263 26 35
NOVOLOG MIX 70-30 305 225 10 27 93
TAMSULOSIN HCL 304 275 28 31
CARVEDILOL 297 240 29 19
ENOXAPARIN SODIUM 292 191 10 30 95
KLOR-CON M20 277 246 31 26
RIVASTIGMINE 276 247 10 32 96
AMLODIPINE BESYLATE 274 193 33 3
AZELASTINE HCL 262 210 34 100
ZOLPIDEM TARTRATE 259 169 35 37
TRAMADOL HCL 253 220 36 18
CLONIDINE HCL 235 136 37 32
HYDROCHLOROTHIAZIDE 228 180 38 23
PANTOPRAZOLE SODIUM 220 179 39 50
HYDRALAZINE HCL 220 182 39 66
DIVALPROEX SODIUM 211 121 41 42
LEXAPRO 207 161 42 81
NOVOLIN R 206 147 43 79
ALLOPURINOL 202 169 44 57
BENZTROPINE MESYLATE 199 110 R 45 70
TRAZODONE HCL 197 110 46 27
DONEPEZIL HCL 192 183 47 11
LACTULOSE 190 151 48 14
DIOVAN 187 161 49 34
SEROQUEL 187 147 49 60
TRAVATAN Z 186 149 51 100
DOXYCYCLINE HYCLATE 181 138 52 94
METOCLOPRAMIDE HCL 175 134 53 105
LANTUS 173 116 54 36
CLOPIDOGREL 171 137 55 30
ADVAIR DISKUS 171 147 55 54
METOPROLOL SUCCINATE 167 131 57 25
FLUTICASONE PROPIONATE 159 100 58 73
ATORVASTATIN CALCIUM 153 107 59 38
CYCLOBENZAPRINE HCL 150 64 R 60 98
GLIPIZIDE 149 89 61 45
ALBUTEROL SULFATE 148 135 62 129
IBUPROFEN 147 101 63 130
CITALOPRAM HBR 143 120 64 29
PLAVIX 138 110 65 43
SERTRALINE HCL 137 123 66 22
TESTOSTERONE CYPIONATE 135 119 S3 67 137
BUMETANIDE 130 103 68 75
CIPROFLOXACIN HCL 125 98 69 87
CYMBALTA 124 79 70 53
CARBIDOPA-LEVODOPA 124 124 70 64
VALPROIC ACID 123 80 72 111
NOVOLIN 70-30 116 82 73 112
DIGOXIN 109 105 74 46
ATENOLOL 108 64 75 40
BACLOFEN 107 29 76 102
CELEBREX 106 96 77 153
PREDNISONE 106 76 77 62
SPIRONOLACTONE 105 49 79 92
CLONIDINE 105 81 79 119
CRESTOR 104 44 81 44
FLUOXETINE HCL 102 43 82 116
RISPERDAL CONSTA 99 74 83 156
HUMULIN R 97 70 84 157
CYPROHEPTADINE HCL 96 93 R 85 127
FINASTERIDE 94 85 86 90
SPIRIVA 92 45 87 83
MIRTAZAPINE 92 82 87 33
ISOSORBIDE MONONITRATE ER 91 87 89 61
HUMALOG 89 59 90 74
ZIPRASIDONE HCL 87 58 91 103
PHENYTOIN SODIUM EXTENDED 87 47 91 67
SANTYL 85 56 93 82
FORTICAL 83 74 94 169
PHENYTOIN 83 72 94 125
COUMADIN 81 71 96 171
ALENDRONATE SODIUM 81 81 96 48
RAMIPRIL 81 72 96 171
DEPO-TESTOSTERONE 76 62 S3 10 99 175
BUSPIRONE HCL 75 44 100 176
HUMULIN 70-30 74 46 101 177
TRICOR 74 41 101 86
MUPIROCIN 74 59 101 138
IPRATROPIUM-ALBUTEROL 74 66 101 89
IPRATROPIUM BROMIDE 71 69 105 180
GLYBURIDE 70 28 R 106 133
HEPARIN SODIUM 68 29 107 182
LATANOPROST 67 58 108 114
CLOTRIMAZOLE-BETAMETHASONE 66 50 109 185
AMIODARONE HCL 66 51 109 127
AMOX TR-POTASSIUM CLAVULANATE 66 55 109 185
TIMOLOL MALEATE 63 51 112 191
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 48 113 58
ABILIFY 62 35 113 194
FLUCONAZOLE 62 53 113 194
PROPRANOLOL HCL 61 27 116 133
NASONEX 60 50 117 197
NIFEDIPINE ER 59 50 118 122
PROAIR HFA 59 47 118 113
FENOFIBRATE 57 31 120 148
ZEMPLAR 57 52 120 203
HYDROXYZINE HCL 57 36 R 120 203
VENLAFAXINE HCL ER 56 38 123 115
LOVASTATIN 54 42 124 90
LABETALOL HCL 53 36 125 211
LOSARTAN POTASSIUM 52 52 126 97
KLOR-CON M10 51 38 127 85
RENVELA 51 22 127 133
OXCARBAZEPINE 51 14 127 213
ZYPREXA 50 36 130 216
BRIMONIDINE TARTRATE 50 50 130 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.